BRIEF-GW Pharmaceuticals says Epidiolex granted orphan drug designation by FDA

Fri Nov 15, 2013 2:15am EST

Related Topics

Nov 15 (Reuters) - GW Pharmaceuticals PLC : * Orphan drug designation granted for epidiolex in dravet syndrome by the FDA * U.S. pediatric epilepsy specialists to treat high need pediatric epilepsy

FILED UNDER: